YH004

DRUG2 trials

Sponsors

Eucure (Beijing) Biopharma Co., Ltd

Conditions

Advanced Solid TumorsCancerRelapsed Or Refractory Non-Hodgkin Lymphoma

Phase 1

Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

CompletedNCT05040932

Eucure (Beijing) Biopharma Co., LtdCancer

Start: 2021-12-07End: 2023-07-16Updated: 2023-09-07

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

RecruitingNCT05564806

Eucure (Beijing) Biopharma Co., LtdAdvanced Solid Tumors, Relapsed Or Refractory Non-Hodgkin Lymphoma

Start: 2023-01-31End: 2026-02-07Target: 38Updated: 2023-09-07